Cargando…
ODP222 Liragluitde Increased IL-1RA Concentrations in Obese Type 2 Diabetes: A Small Randomized Controlled Trial
BACKGROUND: Therapy with exenatide, exendin-4-based glucagon liked peptide-1 receptor agonist (GLP-1 RA) increased plasma interleukin-1 receptor antagonist (IL-1RA), an endogenous anti-inflammatory protein which protected pancreatic ß cells independent of glycemic and weight controlled. We hypothesi...
Autores principales: | Sathavarodom, Nattapol, Roongjiraroj, Thanasate, Pinphanichakarn, Verapon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624849/ http://dx.doi.org/10.1210/jendso/bvac150.673 |
Ejemplares similares
-
Initial Combination Empagliflozin and Linagliptin Improves Kidney Fibrotic Marker in Patients With Type 2 Diabetes: A Randomized Controlled Trial
por: Sathavarodom, Nattapol, et al.
Publicado: (2021) -
ODP171 Choosing GLP-1RA Over Insulin for Patients with Type 2 Diabetes and Severe Hyperglycemia
por: Mamtani, Raashi, et al.
Publicado: (2022) -
ODP250 The Role of Urine Renal Injury Markers in Obese Children and Adolescents with Diabetes Mellitus
por: Bae Ahn, Moon, et al.
Publicado: (2022) -
ODP228 Obesity Induced a Down-Regulation of nNOS in Intrapancreatic Nervous System
por: Huang, Zhihui, et al.
Publicado: (2022) -
ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)